Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations (Q67993236)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1991

Language	Label	Description	Also known as
English	Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations	scientific article published on 01 January 1991

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

A J Beniers

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

R J van Moorselaar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

W P Peelen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

F M Debruyne

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

J A Schalken

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

Urological Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

91-98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

Interferon-alpha: current status and future promise.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunological approach to cancer treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between response to chemotherapy of human tumors in patients and in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of recombinant human interferon gamma (S-6810) on renal cell carcinoma. Summary of two collaborative studies. Recombinant Human Interferon Gamma (S-6810) Research Group on Renal Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive effects of recombinant interferon-alpha during long-term treatment of cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon treatment of renal cell carcinoma. Current status and future prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of initial therapy for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological response modifiers: the new immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells: a new approach to immunotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis and treatment of renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TIL from renal-cell carcinoma: restimulation with tumor influences proliferation and cytolytic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I clinical trial of recombinant human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of scid mice to identify and quantitate lymphoid-restricted stem cells in long-term bone marrow cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon therapy for metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human interferons inhibit experimental metastases of a human melanoma cell line in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma: two new cell lines and a serially transplantable nude mouse tumor (NC 65). Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of mouse interferon on human tumour xenografts in the nude mouse host

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon in renal cell carcinoma. The UCLA experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effects of human lymphoblastoid interferon on advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha-n1 and continuous infusion vinblastine for treatment of advanced renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced anti-tumor effects of recombinant human tumor necrosis factor plus VP-16 on metastatic renal cell carcinoma in a xenograft model

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacillus Calmette-Guerin in the Treatment of Adenocarcinoma of the Kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options in renal-cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiopathic regression of metastases from renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive treatment of metastatic renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for recombinant human interferon-gamma adjuvant immunotherapy for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal therapy and chemotherapy of renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of human renal cell carcinoma into NMRI nu/nu mice. I. Reliability of an experimental tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1 and tumor necrosis factor production by tumor-associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1906659

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00368183

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1906659%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67993236&oldid=2223937284"